THE QUESTION

The weight is coming off. Am I losing muscle too?

THE SIMPLE ANSWER

Possibly. When weight comes off, most of it may be fat, but some can be tissue that includes muscle. A bathroom scale cannot tell the difference.

That does not make GLP-1 medicines bad or make the weight loss unhelpful. It means the plan should pay attention to strength, food, and what your body can do, not only the number on the scale.

WHAT WE KNOW

Body-scan studies of widely used GLP-1-based medicines have found large losses of fat along with some loss of tissue counted as lean mass. Lean mass is a research measurement. It includes muscle, but also water, organs, and other tissue, so it is not an exact measurement of muscle loss.

A 2025 clinical advisory from four medical and nutrition organizations recommends appropriate nutrition and resistance training during GLP-1 treatment to help protect muscle and bone. The plan should fit the woman, her health, her medicines, and what she can safely do.

There is also proven heart benefit in a specific group. In adults who already had cardiovascular disease and also had overweight or obesity, semaglutide lowered the combined risk of cardiovascular death, nonfatal heart attack, or nonfatal stroke. That result should not be stretched to every GLP-1-based medicine or every woman.

Trials of semaglutide and tirzepatide found substantial weight regain after people stopped treatment. The amount varies. A stopping or maintenance plan should be discussed with the prescriber instead of left until the last dose.

WHAT WE DO NOT KNOW YET

We cannot tell from pounds alone how much muscle one woman is losing. We also do not yet have one best protein target, strength plan, or monitoring plan that fits everyone taking these medicines.

Trials do not answer every long-term question about strength and physical function in women across midlife. This is why it makes sense to follow how you feel and function, not just how much you weigh.

WHY THIS MATTERS TO YOUR HEART

Muscle helps you move, use blood sugar, recover, and stay independent. Your heart may deliver the blood and oxygen, but your muscles help turn that delivery into stairs climbed, groceries carried, and years lived with more capacity.

The goal is not simply to weigh less. It is to arrive later with more strength and more room to live your life.

ONE QUESTION TO ASK YOUR CLINICIAN

As I lose weight, how should we protect my strength and notice if I am losing more muscle than expected?

Evidence behind the article

Sources and editorial review

Sources last checked by Lisa for accuracy: September 7, 2026

  1. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 studyDiabetes, Obesity and Metabolism · 2025
  2. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategiesDiabetes, Obesity and Metabolism · 2024
  3. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisoryAmerican Journal of Clinical Nutrition · 2025
  4. Semaglutide and Cardiovascular Outcomes in Obesity without DiabetesThe New England Journal of Medicine · 2023
  5. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extensionDiabetes, Obesity and Metabolism · 2022
  6. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical TrialJAMA · 2024
  7. FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or OverweightU.S. Food and Drug Administration · 2024

Independent clinical review is identified only when it has been completed and approved in writing. No external reviewer or organization is implied. Sources do not imply endorsement of HEART RESERVE.